Drug Type Small molecule drug |
Synonyms WY 47791, WY-47791 |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19ClFN3 |
InChIKeyCYAQJBUCOCJWET-UHFFFAOYSA-N |
CAS Registry136777-43-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Behavioural disorders | Phase 1 | - | - |